NCT07033455View on ClinicalTrials.gov

A Trial of HRS-1893 in Healthy Volunteers

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG

HRS-1893

Single dose of HRS-1893 orally administered

Trial Locations (1)

6009

RECRUITING

Linear Clinical Research, Nedlands

All Listed Sponsors

lead

Atridia Pty Ltd.

INDUSTRY